Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Y-mAbs Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:YMAB | Benzinga

Q: What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Y-mAbs Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for YMAB.

Open	-
Close	-
Volume / Avg.	0 / 404.26K
Day Range	- - -
52 Wk Range	3.86 - 17.78
Market Cap	$215.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	9.8%
Days to Cover	11.23

Recent News

Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Y-mAbs' Omburtamab Failure: The Critical Turning Point And $19.65M Shareholder Settlement

Stan Vick

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 404.26K
Day Range	- - -
52 Wk Range	3.86 - 17.78
Market Cap	$215.88M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	9.8%
Days to Cover	11.23

About Y-Mabs Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the...

Got Questions? Ask

How is YMAB's EV/EBITDA ratio?

What is YMAB's all-time low price?

What is YMAB's drawdown from recent high?

What is the Pivot resistance level for YMAB?

What’s the latest news on YMAB?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Y-mAbs Therapeutics (YMAB) stock?

You can purchase shares of Y-mAbs Therapeutics (NASDAQ:YMAB) through any online brokerage.

View our list of the best stock brokerages

Who are Y-mAbs Therapeutics (YMAB) competitors?

Other companies in Y-mAbs Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Anika Therapeutics (NASDAQ:ANIK), Abeona Therapeutics (NASDAQ:ABEO), Design Therapeutics (NASDAQ:DSGN) and Protalix BioTherapeutics (AMEX:PLX).

What is the forecast, or price target, for Y-mAbs Therapeutics (YMAB) stock?

Y-mAbs Therapeutics has a consensus price target of $18.07.

What is the current price for Y-mAbs Therapeutics (YMAB)?

The stock price for Y-mAbs Therapeutics (NASDAQ: YMAB) is $4.82 last updated April 21, 2025 at 4:00 PM EDT.

Does Y-mAbs Therapeutics (YMAB) pay a dividend?

There are no upcoming dividends for Y-mAbs Therapeutics.

When is Y-mAbs Therapeutics (NASDAQ:YMAB) reporting earnings?

Y-mAbs Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Y-mAbs Therapeutics (YMAB) going to split?

There is no upcoming split for Y-mAbs Therapeutics.

What sector and industry does Y-mAbs Therapeutics (YMAB) operate in?

Y-mAbs Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Y-mAbs Therapeutics Stock Price, Quotes and Forecasts

Y-mAbs Therapeutics (YMAB) Forecast